A 71-year-old with T2D and UACR 220 mg/g on ACE inhibitor started on dapagliflozin. He asks about expected effects. Which is true?...

Question

A 71-year-old with T2D and UACR 220 mg/g on ACE inhibitor started on dapagliflozin. He asks about expected effects. Which is true?

Accepted Answer

SGLT2s reduce CKD progression and HF hospitalization

Answer

CKD3a

Answer

and UACR 220 mg/g on ACE inhibitor started on dapagliflozin. He asks about expected effects. Which is true?

Answer

Initial eGFR rise indicates harm

Answer

They increase DKA risk in type 2 diabetes always prohibiting use

ukmla MCQ (SBA): Type 2 Diabetes Mellitus